Effect of triple therapy with extra-fine BDP/FF/GB pMDI vs non-triple maintenance therapies on severe COPD exacerbations. A pooled analysis of the TRILOGY, TRINITY and TRIBUTE studies.
D. Singh (Manchester, United Kingdom), E. Clini (Reggio Emilia, Italy), A. Papi (Ferrara, Italy), A. Piraino (Parma, Italy), E. Nudo (Parma, Italy), A. Guasconi (Parma, Italy), G. Georges (Parma, Italy), J. Vestbo (Manchester, United Kingdom)
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Singh (Manchester, United Kingdom), E. Clini (Reggio Emilia, Italy), A. Papi (Ferrara, Italy), A. Piraino (Parma, Italy), E. Nudo (Parma, Italy), A. Guasconi (Parma, Italy), G. Georges (Parma, Italy), J. Vestbo (Manchester, United Kingdom). Effect of triple therapy with extra-fine BDP/FF/GB pMDI vs non-triple maintenance therapies on severe COPD exacerbations. A pooled analysis of the TRILOGY, TRINITY and TRIBUTE studies.. 979
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: